Nuvation BioNUVB +6.95%33 FCF Margin % is 6.03% as of Mar. 2026. GuruFocus rates NUVB with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Nuvation Bio ranks worse than 51.62% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nuvation Bio's Free Cash Flow for the
three
months ended in Mar. 2026 was $5.0 Mil. Nuvation Bio's Revenue for the
three
months ended in Mar. 2026 was $83.2 Mil. Therefore, Nuvation Bio's FCF Margin % for the quarter that ended in Mar. 2026 was 6.03%.
The historical rank and industry rank for Nuvation Bio's FCF Margin % or its related term are showing as below:
NUVB'
s FCF Margin % Range Over the Past 10 Years
Min: -1658.52 Med: -973.76 Max: -93.72
Current: -93.72
During the past 6 years, the highest FCF Margin % of Nuvation Bio was -93.72%. The lowest was -1658.52%. And the median was -973.76%.
NUVB's FCF Margin % is ranked worse than 51.62% of 959
companies
in the Biotechnology industry
Industry Median: -84.65
vs NUVB: -93.72
Nuvation Bio FCF Margin % Related Terms
Nuvation Bio FCF Margin % Historical Data
* Premium members only.
The historical data trend for Nuvation Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Nuvation Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuvation Bio FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nuvation Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Nuvation Bio's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuvation Bio (NUVB) has a FCF Margin % of 6.03% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nuvation Bio and its competitors. According to the industry distribution chart, Nuvation Bio ranks #495 out of 959 companies in the Biotechnology industry, placing it in the top 51.6%.
Is Nuvation Bio's FCF Margin % too high?
Nuvation Bio's current FCF Margin % is 6.03%. Based on the distribution chart, Nuvation Bio ranks #495 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nuvation Bio has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Nuvation Bio's FCF Margin % compare to GLUE and ATAI?
According to the Biotechnology industry distribution chart, Nuvation Bio ranks #495 out of 959 companies for FCF Margin %. This places Nuvation Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nuvation Bio and its competitors. Nuvation Bio's current FCF Margin % is 6.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuvation Bio stock overvalued right now?
Nuvation Bio (NUVB) has a current FCF Margin % of 6.03%. The current FCF Margin % is 6.03%. Nuvation Bio's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Nuvation Bio (NUVB), the current FCF Margin % is 6.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
33GF Score
Get the complete analysis for NUVB
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUVB has been successfully added to your 
